Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Erika Bereczki"'
Autor:
Hazal Haytural, Rui Benfeitas, Sophia Schedin-Weiss, Erika Bereczki, Melinda Rezeli, Richard D. Unwin, Xusheng Wang, Eric B. Dammer, Erik C. B. Johnson, Nicholas T. Seyfried, Bengt Winblad, Betty M. Tijms, Pieter Jelle Visser, Susanne Frykman, Lars O. Tjernberg
Publikováno v:
Scientific Data, Vol 8, Iss 1, Pp 1-11 (2021)
Abstract Mass spectrometry (MS)-based proteomics is a powerful tool to explore pathogenic changes of a disease in an unbiased manner and has been used extensively in Alzheimer disease (AD) research. Here, by performing a meta-analysis of high-quality
Externí odkaz:
https://doaj.org/article/d189ee05892c4b5e8df9e6a2031f9246
Autor:
Dina Medina-Vera, Hongjing Zhao, Erika Bereczki, Cristina Rosell-Valle, Makoto Shimozawa, Gefei Chen, Fernando Rodríguez de Fonseca, Per Nilsson, Simone Tambaro
Publikováno v:
Biology, Vol 12, Iss 6, p 805 (2023)
Background: The endocannabinoid system (ECS) and associated lipid transmitter-based signaling systems play an important role in modulating brain neuroinflammation. ECS is affected in neurodegenerative disorders, such as Alzheimer’s disease (AD). He
Externí odkaz:
https://doaj.org/article/97e68dfdb67d4382b3c85ca13d2c9f52
Autor:
Erika Bereczki, Anna Bogstedt, Kina Höglund, Panagiota Tsitsi, Lovisa Brodin, Clive Ballard, Per Svenningsson, Dag Aarsland
Publikováno v:
npj Parkinson's Disease, Vol 3, Iss 1, Pp 1-5 (2017)
Biomarkers: Synaptic proteins give it away The levels of synaptic proteins in the cerebrospinal fluid (CSF) correlate with Parkinson’s disease (PD) severity. Dysfunctional communication between nerve cells is an established hallmark of early stage
Externí odkaz:
https://doaj.org/article/388e5cf2ffc74b24ba90cf4aac03e2f8
Autor:
Nikolett Lénárt, Viktor Szegedi, Gábor Juhász, Aniko Kasztner, János Horváth, Erika Bereczki, Melinda E Tóth, Botond Penke, Miklós Sántha
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e46007 (2012)
AimsApoB-100 is the major protein component of cholesterol- and triglyceride-rich LDL and VLDL lipoproteins in the serum. Previously, we generated and partially described transgenic mice overexpressing the human ApoB-100 protein. Here, we further cha
Externí odkaz:
https://doaj.org/article/50388ac2af4d4398862f55cad7d2d37b
Autor:
Tambaro, Dina Medina-Vera, Hongjing Zhao, Erika Bereczki, Cristina Rosell-Valle, Makoto Shimozawa, Gefei Chen, Fernando Rodríguez de Fonseca, Per Nilsson, Simone
Publikováno v:
Biology; Volume 12; Issue 6; Pages: 805
Background: The endocannabinoid system (ECS) and associated lipid transmitter-based signaling systems play an important role in modulating brain neuroinflammation. ECS is affected in neurodegenerative disorders, such as Alzheimer’s disease (AD). He
Autor:
Kärt Mätlik, Daniel R. Garton, Ana R. Montaño-Rodríguez, Soophie Olfat, Feride Eren, Laoise Casserly, Anastasios Damdimopoulos, Anne Panhelainen, L. Lauriina Porokuokka, Jaakko J. Kopra, Giorgio Turconi, Nadine Schweizer, Erika Bereczki, Fredrik Piehl, Göran Engberg, Simon Cervenka, T. Petteri Piepponen, Fu-Ping Zhang, Petra Sipilä, Johan Jakobsson, Carl M. Sellgren, Sophie Erhardt, Jaan-Olle Andressoo
Publikováno v:
Molecular Psychiatry. 27:3247-3261
Presynaptic increase in striatal dopamine is the primary dopaminergic abnormality in schizophrenia, but the underlying mechanisms are not understood. Here, we hypothesized that increased expression of endogenous GDNF could induce dopaminergic abnorma
Autor:
Luana Naia, Makoto Shimozawa, Erika Bereczki, Xidan Li, Jianping Liu, Richeng Jiang, Nuno Santos Leal, Catarina Moreira Pinho, Erik Berger, Victoria Lim Falk, Giacomo Dentoni, Maria Ankarcrona, Per Nilsson
Increased amyloid β-peptide (Aβ) level is one of the drivers of Alzheimer’s disease (AD). Amyloid precursor protein (App) knock-in mice recapitulate the human Aβ pathology, allowing the elucidation of the downstream effects of Aβ and their temp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfbd5fff7ae9a7942aea1145d6bbd7ad
https://doi.org/10.1101/2023.03.07.531542
https://doi.org/10.1101/2023.03.07.531542
Autor:
Dina Medina-Vera, Daniela Enache, Simone Tambaro, Ethar Abuhashish, Cristina Rosell-Valle, Bengt Winblad, Fernando Rodríguez de Fonseca, Erika Bereczki, Per Nilsson
Publikováno v:
Brain Communications. 5
Synaptic dysfunction is an early event in Alzheimer’s disease. Post-mortem studies suggest that alterations in synaptic proteins are associated with cognitive decline in Alzheimer’s disease. We measured the concentration of three synaptic protein
Autor:
Erika Bereczki, Bengt Winblad, Dag Aarsland, Vesna Jelic, Joana B. Pereira, Daniela Enache, Per Nilsson
Publikováno v:
Journal of Alzheimer's Disease. 77:1143-1155
Background: Cognitive deficits arising in the course of Alzheimer’s disease (AD), dementia with Lewy bodies (DLB), and Parkinson’s disease with dementia (PDD) are directly linked to synaptic loss. Postmortem studies suggest that zinc transporter
Autor:
Saffron K. Smith, Benjamin Kottler, Jessika Cristina Bridi, Gonçalo M. Poças, Dag Aarsland, Frank Hirth, Christopher J. H. Elliott, Erika Bereczki, Pedro Domingos
Alpha-synuclein (α-syn) mislocalisation and accumulation in intracellular inclusions is the major pathological hallmark of degenerative synucleinopathies, including Parkinson’s disease, Parkinson’s disease with Dementia and Dementia with Lewy Bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb88da2e0583fcfebd45a7c89abf14d9
https://doi.org/10.1101/2020.10.12.335778
https://doi.org/10.1101/2020.10.12.335778